Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 15, 2008
Grant Date -
Dec 8, 2005
app pub date -
May 18, 2005
filing date -
May 20, 2004
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully